Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash Flows From Operating Activities:
Net income (loss)	$ 1,653	$ (583,165)
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:
Depreciation and amortization	442,408	449,648
Accretion of asset retirement obligation	1,732	4,386
Common stock payable for directors fees	56,250	61,733
Gain on settlement of Hillgrove advance	(113,422)	0
Gain on forgiveness of Cares Act debt	(443,400)	0
Write-down of inventory to net realizable value	66,054	0
Other non-cash items	0	(48)
Change in:
Accounts receivable	(362,681)	50,817
Inventories	17,448	39,890
IVA receivable and other assets	(15,402)	(43,952)
Accounts payable	(519,570)	(256,368)
Accrued liabilities	(92,927)	(23,668)
Export tax assessment payable	(1,120,730)	0
Payables to related parties	(154,022)	21,405
Net cash (used) by operating activities	(2,236,609)	(279,322)
Cash Flows From Investing Activities:
Proceeds from redemption of certificates of deposit	210,184	0
Purchase of properties, plants and equipment	(115,127)	(200,166)
Net cash provided (used) by investing activities	95,057	(200,166)
Cash Flows From Financing Activities:
Change in checks issued and payable	(86,685)	142,530
Payments on advances from related party	(56,416)	(46,160)
Proceeds from note payable-SBA	0	443,400
Proceeds from issuance of common stock, net of issuance costs	23,342,180	0
Proceeds from exercise of warrants	1,790,703	0
Payments on Hillgrove advances payable	(1,020,799)	0
Borrowing on notes payable to bank	0	(31,135)
Principal paid on notes payable to bank	(100,000)	(21,238)
Principal payments of long-term debt	(27,926)	0
Net cash provided by financing activities	23,841,057	487,397
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH	21,699,505	7,909
Cash and cash equivalents and restricted cash at beginning of period	722,377	172,767
Cash and cash equivalents and restricted cash at end of period	22,421,882	180,676
NONCASH INVESTING AND FINANCING ACTIVITIES:
Common stock payable issued to directors	0	130,483
Payable to related party satisfied with exercise of stock	$ 0	$ 62,500